Exelixis Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Exelixis
EXEL Stock  USD 40.37  0.37  0.91%   
Exelixis' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Exelixis' valuation are provided below:
Gross Profit
2.2 B
Profit Margin
0.2799
Market Capitalization
11 B
Enterprise Value Revenue
4.4217
Revenue
2.3 B
There are over one hundred nineteen available fundamental signals for Exelixis, which can be analyzed over time and compared to other ratios. We recommend to verify Exelixis' prevailing fundamental drivers against the all of the trends between 2010 and 2025. Market Cap is expected to rise to about 1.8 B this year. Enterprise Value is expected to rise to about 1.9 B this year

Exelixis Total Revenue

2.28 Billion

Check Exelixis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Exelixis' main balance sheet or income statement drivers, such as Interest Expense of 64.9 M, Total Revenue of 2.3 B or Gross Profit of 2.2 B, as well as many indicators such as Price To Sales Ratio of 4.01, Dividend Yield of 0.0 or PTB Ratio of 2.6. Exelixis financial statements analysis is a perfect complement when working with Exelixis Valuation or Volatility modules.
  
Build AI portfolio with Exelixis Stock
Check out the analysis of Exelixis Correlation against competitors.
For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.

Exelixis Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.1 B2.9 B1.5 B
Slightly volatile
Common Stock Shares Outstanding183.9 M296.1 M239.8 M
Slightly volatile
Liabilities And Stockholders Equity3.1 B2.9 B1.5 B
Slightly volatile
Other Stockholder Equity1.5 B2.3 B1.9 B
Slightly volatile
Short and Long Term Debt Total180.8 M190.8 M203.7 M
Pretty Stable
Other Current Liabilities383.9 M365.6 M146.9 M
Slightly volatile
Total Current Liabilities424 M403.8 M201.1 M
Slightly volatile
Property Plant And Equipment Net377.1 M359.1 M113.9 M
Slightly volatile
Accounts Payable40.1 M38.2 M16.5 M
Slightly volatile
Cash192.8 M217.4 M227 M
Slightly volatile
Non Current Assets Total1.6 B1.5 B643.5 M
Slightly volatile
Non Currrent Assets Other70.1 M66.8 M38.7 M
Slightly volatile
Cash And Short Term Investments1.2 B1.1 B673.4 M
Slightly volatile
Net Receivables278.7 M265.4 M119.2 M
Slightly volatile
Short Term Investments938.6 M893.9 M444.2 M
Slightly volatile
Non Current Liabilities Total217.6 M299.7 M208.2 M
Very volatile
Other Current Assets71.9 M68.5 M31.7 M
Slightly volatile
Total Liabilities385.8 M703.5 M393.3 M
Slightly volatile
Total Current Assets1.5 B1.5 B835.7 M
Slightly volatile
Short Term Debt50.4 M29.6 M61.9 M
Pretty Stable
Common Stock267.9 K282 K1.5 M
Slightly volatile
Other Liabilities83.4 M78.8 M57.1 M
Pretty Stable
Other Assets346.4 M329.9 M136.1 M
Slightly volatile
Good Will51.2 M57.3 M61.9 M
Pretty Stable
Common Stock Total Equity391.2 K372.6 K249.7 K
Slightly volatile
Property Plant And Equipment Gross482.8 M459.8 M149.4 M
Slightly volatile
Intangible Assets49.7 M57.3 M62.1 M
Slightly volatile
Property Plant Equipment133.6 M127.2 M54.9 M
Slightly volatile
Current Deferred Revenue4.6 M4.9 M18.8 M
Pretty Stable
Long Term Debt Total67.5 K71.1 K105.3 M
Slightly volatile
Capital Surpluse2.1 B2.9 B2 B
Slightly volatile
Long Term Investments331.3 M637.3 M289.6 M
Slightly volatile
Non Current Liabilities Other114.3 M108.9 M49.6 M
Slightly volatile
Short and Long Term Debt2.3 M2.5 M69.9 M
Slightly volatile
Net Invested Capital2 B2.2 B1.1 B
Slightly volatile
Net Working Capital1.1 B1.1 B734 M
Slightly volatile
Capital Lease Obligations115.4 M190.8 M59.2 M
Slightly volatile
Capital Stock245.1 K282 K299.4 K
Pretty Stable

Exelixis Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Revenue2.3 B2.2 B825.5 M
Slightly volatile
Gross Profit2.2 B2.1 B796.5 M
Slightly volatile
Other Operating Expenses1.6 B1.6 B676.1 M
Slightly volatile
Research Development955.9 M910.4 M408.3 M
Slightly volatile
Total Operating Expenses1.6 B1.5 B647.1 M
Slightly volatile
Depreciation And Amortization30.2 M28.8 M10.7 M
Slightly volatile
Selling General Administrative516.7 M492.1 M228.7 M
Slightly volatile
Interest Income81 M77.2 M23.8 M
Slightly volatile
Selling And Marketing Expenses28.3 M46 M19.6 M
Slightly volatile
Reconciled Depreciation15.8 M28.8 M8.7 M
Slightly volatile

Exelixis Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow184.4 M263 M220.5 M
Slightly volatile
Depreciation30.2 M28.8 M10.7 M
Slightly volatile
Capital Expenditures69.5 M66.2 M38.3 M
Slightly volatile
End Period Cash Flow193.7 M217.4 M228.5 M
Slightly volatile
Stock Based Compensation98.5 M93.8 M52.9 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.014.54312.5346
Slightly volatile
Days Sales Outstanding71.944.67454.5744
Slightly volatile
Stock Based Compensation To Revenue0.08350.04330.221
Slightly volatile
Capex To Depreciation4.712.29792.2017
Slightly volatile
EV To Sales3.64.530714.7867
Slightly volatile
Inventory Turnover1.923.40431.8692
Slightly volatile
Days Of Inventory On Hand190107257
Slightly volatile
Payables Turnover2.181.99571.3058
Slightly volatile
Sales General And Administrative To Revenue0.260.22690.7732
Slightly volatile
Research And Ddevelopement To Revenue0.480.41981.7224
Slightly volatile
Capex To Revenue0.04480.03050.0311
Pretty Stable
Cash Per Share4.663.83162.9209
Slightly volatile
Days Payables Outstanding167183542
Slightly volatile
Income Quality1.731.34281.3213
Slightly volatile
Intangibles To Total Assets0.02430.02160.084
Slightly volatile
Current Ratio5.433.63474.5289
Slightly volatile
Receivables Turnover5.088.17037.0475
Slightly volatile
Graham Number10.7717.68939.5108
Slightly volatile
Capex Per Share0.20.22820.1038
Slightly volatile
Revenue Per Share4.567.47753.1134
Slightly volatile
Interest Debt Per Share0.160.65790.8981
Slightly volatile
Debt To Assets0.01960.06470.3635
Slightly volatile
Operating Cycle262152296
Slightly volatile
Days Of Payables Outstanding167183542
Slightly volatile
Ebt Per Ebit1.031.12741.1964
Slightly volatile
Quick Ratio5.353.57934.464
Slightly volatile
Net Income Per E B T0.790.76470.8811
Slightly volatile
Cash Ratio1.920.53841.4656
Pretty Stable
Days Of Inventory Outstanding190107257
Slightly volatile
Days Of Sales Outstanding71.944.67454.5744
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.840.90540.9436
Slightly volatile
Fixed Asset Turnover13.796.039113.6636
Slightly volatile
Debt Ratio0.01960.06470.3635
Slightly volatile
Price Sales Ratio4.014.54312.5346
Slightly volatile
Asset Turnover0.550.73570.4082
Slightly volatile
Gross Profit Margin0.960.96490.9438
Slightly volatile

Exelixis Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.8 B1 B5.6 B
Pretty Stable
Enterprise Value1.9 B1.2 B5.6 B
Pretty Stable

Exelixis Fundamental Market Drivers

Forward Price Earnings20.202
Cash And Short Term Investments1.1 B

Exelixis Upcoming Events

6th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Exelixis Financial Statements

Exelixis investors utilize fundamental indicators, such as revenue or net income, to predict how Exelixis Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue4.9 M4.6 M
Total Revenue2.2 B2.3 B
Cost Of Revenue76.2 M55.7 M
Stock Based Compensation To Revenue 0.04  0.08 
Sales General And Administrative To Revenue 0.23  0.26 
Research And Ddevelopement To Revenue 0.42  0.48 
Capex To Revenue 0.03  0.04 
Revenue Per Share 7.48  4.56 
Ebit Per Revenue 0.28  0.20 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Exelixis is a strong investment it is important to analyze Exelixis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Exelixis' future performance. For an informed investment choice regarding Exelixis Stock, refer to the following important reports:
How To Invest In Exelixis
Details
Is Exelixis Stock a good investment?
Details
What is Exelixis' Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Exelixis Correlation against competitors.
For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exelixis. If investors know Exelixis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exelixis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
3.583
Earnings Share
2.19
Revenue Per Share
8.079
Quarterly Revenue Growth
0.306
Return On Assets
0.1805
The market value of Exelixis is measured differently than its book value, which is the value of Exelixis that is recorded on the company's balance sheet. Investors also form their own opinion of Exelixis' value that differs from its market value or its book value, called intrinsic value, which is Exelixis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exelixis' market value can be influenced by many factors that don't directly affect Exelixis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Exelixis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Exelixis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exelixis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY